The treatment landscape for International Lambert-Eaton Myasthenic Syndrome (LEMS) is dynamically changing. While there is no cure present, a variety of treatment options are available to manage symptoms and improve quality of life. Frequently prescribed therapies include corticosteroids, aimed at regulating the immune system's action. In the past